Summary
Signal counts
Assets tracked: 4
Watchlist assets: 2
Registry stop assets: 0
Sponsor overview
Fred Hutchinson Cancer Center
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT00118352 | https://clinicaltrials.gov/study/NCT06236139 | https://clinicaltrials.gov/study/NCT07667335 | https://clinicaltrials.gov/study/NCT00003195
Assets
Linked programs
- alemtuzumab: Low Signal (1/5)
- Anti-STEAP1 CAR T-cells: Operational Burden Signal (2/5)
- Quemliclustat: Low Signal (1/5)
- recombinant interferon alfa: Results Not Found Signal (2/5)